BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16002265)

  • 1. Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia.
    Johannesen JK; Kieffaber PD; O'Donnell BF; Shekhar A; Evans JD; Hetrick WP
    Schizophr Res; 2005 Oct; 78(2-3):269-84. PubMed ID: 16002265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal beta and gamma frequency neural oscillations mediate auditory sensory gating deficit in schizophrenia.
    Nguyen AT; Hetrick WP; O'Donnell BF; Brenner CA
    J Psychiatr Res; 2020 May; 124():13-21. PubMed ID: 32109667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P50, N100, and P200 Auditory Sensory Gating Deficits in Schizophrenia Patients.
    Shen CL; Chou TL; Lai WS; Hsieh MH; Liu CC; Liu CM; Hwu HG
    Front Psychiatry; 2020; 11():868. PubMed ID: 33192632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory gating deficit in a subtype of chronic schizophrenic patients.
    Ringel TM; Heidrich A; Jacob CP; Pfuhlmann B; Stoeber G; Fallgatter AJ
    Psychiatry Res; 2004 Mar; 125(3):237-45. PubMed ID: 15051184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives.
    Hall MH; Taylor G; Salisbury DF; Levy DL
    Schizophr Bull; 2011 Nov; 37(6):1187-99. PubMed ID: 20363872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of spectral frequency analyses to the study of P50 ERP amplitude and suppression in bipolar disorder with or without a history of psychosis.
    Carroll CA; Kieffaber PD; Vohs JL; O'Donnell BF; Shekhar A; Hetrick WP
    Bipolar Disord; 2008 Nov; 10(7):776-87. PubMed ID: 19032709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in P50 and prepulse inhibition of the startle reflex between male smokers and non-smokers with first episode schizophrenia without medical treatment.
    Song L; Chen X; Chen M; Tang Y; Wang J; Zhang M; Lou F; Liang J; Chen C
    Chin Med J (Engl); 2014; 127(9):1651-5. PubMed ID: 24791869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multichannel electroencephalographic assessment of auditory evoked response suppression in schizophrenia.
    Clementz BA; Blumenfeld LD
    Exp Brain Res; 2001 Aug; 139(4):377-90. PubMed ID: 11534861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?
    Micoulaud-Franchi JA; Hetrick WP; Aramaki M; Bolbecker A; Boyer L; Ystad S; Kronland-Martinet R; Richieri R; Faget C; Faugere M; El-Kaim A; Cermolacce M; Lancon C; Vion-Dury J
    Schizophr Res; 2014 Aug; 157(1-3):157-62. PubMed ID: 24893905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia.
    Louchart-de la Chapelle S; Levillain D; Ménard JF; Van der Elst A; Allio G; Haouzir S; Dollfus S; Campion D; Thibaut F
    Psychiatry Res; 2005 Jul; 136(1):27-34. PubMed ID: 16014313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
    Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M50 sensory gating predicts negative symptoms in schizophrenia.
    Thoma RJ; Hanlon FM; Moses SN; Ricker D; Huang M; Edgar C; Irwin J; Torres F; Weisend MP; Adler LE; Miller GA; Canive JM
    Schizophr Res; 2005 Mar; 73(2-3):311-8. PubMed ID: 15653276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and environmental influences on sensory gating of mid-latency auditory evoked responses: a twin study.
    Anokhin AP; Vedeniapin AB; Heath AC; Korzyukov O; Boutros NN
    Schizophr Res; 2007 Jan; 89(1-3):312-9. PubMed ID: 17014995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensory gating P50 in schizophrenic patients with and without homicide].
    Wang HX; Zhen WF; Ma X; Wang YP; Tian JH; Dou QS; Zhao HX
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2616-20. PubMed ID: 20137678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects.
    Ghisolfi ES; Prokopiuk AS; Becker J; Ehlers JA; Belmonte-de-Abreu P; Souza DO; Lara DR
    Neuropsychopharmacology; 2002 Oct; 27(4):629-37. PubMed ID: 12377399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient information?
    Brenner CA; Kieffaber PD; Clementz BA; Johannesen JK; Shekhar A; O'Donnell BF; Hetrick WP
    Schizophr Res; 2009 Sep; 113(2-3):332-8. PubMed ID: 19628376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients.
    Brockhaus-Dumke A; Schultze-Lutter F; Mueller R; Tendolkar I; Bechdolf A; Pukrop R; Klosterkoetter J; Ruhrmann S
    Biol Psychiatry; 2008 Sep; 64(5):376-84. PubMed ID: 18395700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P50 and acoustic startle gating are not related in healthy participants.
    Brenner CA; Edwards CR; Carroll CA; Kieffaber PD; Hetrick WP
    Psychophysiology; 2004 Sep; 41(5):702-8. PubMed ID: 15318876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory gating revisited: relation between brain oscillations and auditory evoked potentials in schizophrenia.
    Brockhaus-Dumke A; Mueller R; Faigle U; Klosterkoetter J
    Schizophr Res; 2008 Feb; 99(1-3):238-49. PubMed ID: 18160261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.